Mohammadreza Babaei: Anticoagulation versus No Anticoagulation after Intracranial Hemorrhage in Patients with Atrial Fibrillation
Amir Ghaffari Jolfayi, Research Assistant at Rajaie Cardiovascular, Medical and Research Institute, quoted Mohammadreza Babaei’s post on LinkedIn:
“Excited to share our latest publication in BMC Cardiovascular Disorders!
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Key findings: This meta-analysis of five randomized controlled trials shows that anticoagulation reduces thromboembolic events in patients with atrial fibrillation after intracranial hemorrhage, but is associated with a notably higher risk of recurrent bleeding. It underscores the need for personalized, patient-specific decision-making to balance these risks and benefits.
Special Thanks to Mohammadreza Babaei and the team!
Read the full article here”
Title: Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis
Authors: Mohammadreza Babaei, Parisa Fallahtafti, Sina Rashedi, Amir Ghaffari Jolfayi, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini, Hamidreza Soleimani
Quoting Mohammadreza Babaei’s post:
“Check out our recently published article in BMC Cardiovascular Disorders, titled:
“Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis”
The results of this meta-analysis of five RCTs suggest that anticoagulation provides clinically meaningful reductions in thromboembolic events, but at the cost of a significantly increased risk of bleeding in this population. These findings indicate the importance of carefully selecting patients on an individual basis when weighing the benefits and risks of therapy.
Many thanks to the team members, Parisa Fallahtafti, Sina Rashedi, and Amir Ghaffari Jolfayi for their dedication, and our professors Hamidreza Soleimani, Zahra Hosseini, Kaveh Hosseini, Masih Tajdini for their support and guidance.”
Discover the latest in Hemostasis Today.
-
Dec 21, 2025, 15:35Dr. Tareq Abadl: Low-Titer Group O Whole Blood – Faster, Simpler Resuscitation for Severe Hemorrhage
-
Dec 21, 2025, 15:19Salvatore Massimo Petrina: High D-Dimer, Negative CT Scan – What’s Your Next Move?
-
Dec 21, 2025, 15:10Oliver Tiebel Invites You to the 4th Dresden Symposium: Hemostasis in AINS 2026
-
Dec 21, 2025, 14:24Strengthening Hematology Field: Livingstone Dogara’s Experience in the ASH Visitor Training Program
-
Dec 21, 2025, 13:54Jessica Herzig on CD86 Expression Correlation with Immune Cell Activation
-
Dec 21, 2025, 13:13Aboubacar Sidiki Doukoure on The WFH Hemophilia Care Training in Guinea
-
Dec 21, 2025, 08:12The Role of Viscoelastic Testing in Assessing Hemostasis: A Challenge to Standard Laboratory Assays?
-
Dec 21, 2025, 07:24Heghine Khachatryan: World Federation of Hemophilia Is Far More Than An Organization
-
Dec 21, 2025, 07:21Arsene Mekinian Announces New Expert Clinic for Refractory Hemato-Immunologic Diseases